glp-1/gip vs tirzepatide When it comes to the different types of GLP-1s, like vs. semaglutide, what's the difference? Our endocrine clinical pharmacist explains GLP-1/GIP dual agonist tirzepatide normalizes

Triglyceride reductions typically lead, followed by gradual HDL elevation and modest LDL decreases

Tobacco Use Disorder Outcomes Wang, Volkow, and colleagues also conducted a study of 222,942 individuals with tobacco use disorder and type 2 diabetes, with findings showing individuals prescribed semaglutide showed a 32% lower risk of tobacco-related healthcare visits and were less likely to need smoking cessation medications or counseling during the 12-month follow-up period, with the most notable effects appearing within the first 30 days (Wang et al., 2024c)

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

What matters most is having options that feel comfortable, flexible, and realistic for where you're at